Endocrinological analysis of 122 Japanese childhood cancer survivors in a single hospital.
With recent improvements in the diagnosis and treatment of cancer, the number of childhood cancer survivors (CCSs) has been increasing in Japan. The importance of quality of life during the lifetime of CCSs has now been recognized, and the late effects of cancer treatments are essential and important issues. In this study we analyzed the endocrinological abnormalities of CCSs by retrospectively evaluating 122 outpatients (62 males and 60 females) who had been referred from pediatric oncologists to our follow-up clinic among 151 CCSs attending our hospital more than two years after their cancer treatment. Follow-up duration varied from 2 to 30 (median 8.0) years. Their average age was 17.3 (range 4-36, median 17.0) years, and 38 patients (31.1%) reached adulthood. Endocrinological abnormalities were found in 82 (67%) of 122 survivors. Gonadal dysfunction was observed in 60 patients (49%). Thirty-nine patients (32%) were short or grew at a slower rate. Twenty-six patients (21%) showed thyroid dysfunction. Other abnormalities were as follows: obesity in 20 patients (16%), leanness in 10 (8%), central diabetes insipidus in 11 (9%) and adrenocortical dysfunction in 9 (7%). Low bone mineral density was observed in 41 (42%) of 98 patients evaluated. These endocrinological abnormalities were caused by the combined effects of cancer itself and various treatments (chemotherapy, radiation therapy, surgery, and hematopoietic stem cell transplantation). Lifetime medical surveillance and continuous follow-up are necessary for CCSs, because treatment-related complications may occur during childhood and many years after the therapy as well. Endocrinologists should participate in long-term follow-up of these survivors in collaboration with pediatric oncologists.
Miyoshi
Yoko
Y
Department of Pediatrics, Osaka University Graduate School of Medicine, Suita City, Osaka, Japan.
Ohta
Hideaki
H
Hashii
Yoshiko
Y
Tokimasa
Sadao
S
Namba
Noriyuki
N
Mushiake
Sotaro
S
Hara
Junichi
J
Ozono
Keiichi
K
D000293:Adolescent; D000328:Adult; D002648:Child; D002657:Child Development / Q000502:physiology; D002675:Child, Preschool; D003940:Diagnostic Techniques, Endocrine; D004700:Endocrine System Diseases / Q000175:diagnosis* / Q000453:epidemiology*; D005260:Female; D005500:Follow-Up Studies; D006066:Gonads / Q000502:physiology; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008297:Male; D009369:Neoplasms / Q000453:epidemiology* / Q000628:therapy; D011627:Puberty / Q000502:physiology; D012189:Retrospective Studies; D017741:Survivors / Q000706:statistics & numerical data; D055815:Young Adult